Novartis India's Board announced the completion of the open offer and the sale of 17,450,680 equity shares by Novartis AG to WaveRise Investments, ChrysCapital Fund X, and Two Infinity Partners. This transitions Novartis AG from promoter to public shareholder, as WaveRise and Fund X now hold control. The Board also appointed three new non-executive and three independent directors, while noting the resignations of six previous directors, including the Chairperson, CEO, and CFO. This major board restructuring reflects the company's new ownership structure.